42 related articles for article (PubMed ID: 18571434)
1. Protein-peptide complex crystallization: a case study on the ERK2 mitogen-activated protein kinase.
Gógl G; Törő I; Reményi A
Acta Crystallogr D Biol Crystallogr; 2013 Mar; 69(Pt 3):486-9. PubMed ID: 23519423
[TBL] [Abstract][Full Text] [Related]
2. Determining Cysteines Available for Covalent Inhibition Across the Human Kinome.
Zhao Z; Liu Q; Bliven S; Xie L; Bourne PE
J Med Chem; 2017 Apr; 60(7):2879-2889. PubMed ID: 28326775
[TBL] [Abstract][Full Text] [Related]
3. Covalent docking using autodock: Two-point attractor and flexible side chain methods.
Bianco G; Forli S; Goodsell DS; Olson AJ
Protein Sci; 2016 Jan; 25(1):295-301. PubMed ID: 26103917
[TBL] [Abstract][Full Text] [Related]
4. Investigation of the flexibility of protein kinases implicated in the pathology of Alzheimer's disease.
Mazanetz MP; Laughton CA; Fischer PM
Molecules; 2014 Jun; 19(7):9134-59. PubMed ID: 24983862
[TBL] [Abstract][Full Text] [Related]
5. Exploring aigialomycin d and its analogues as protein kinase inhibitors for cancer targets.
Xu J; Chen A; Go ML; Nacro K; Liu B; Chai CL
ACS Med Chem Lett; 2011 Sep; 2(9):662-6. PubMed ID: 24900361
[TBL] [Abstract][Full Text] [Related]
6. Kinase inhibition by deoxy analogues of the resorcylic lactone L-783277.
Liniger M; Neuhaus C; Hofmann T; Fransioli-Ignazio L; Jordi M; Drueckes P; Trappe J; Fabbro D; Altmann KH
ACS Med Chem Lett; 2011 Jan; 2(1):22-7. PubMed ID: 24900250
[TBL] [Abstract][Full Text] [Related]
7. Hypothemycin, a fungal natural product, identifies therapeutic targets in Trypanosoma brucei [corrected].
Nishino M; Choy JW; Gushwa NN; Oses-Prieto JA; Koupparis K; Burlingame AL; Renslo AR; McKerrow JH; Taunton J
Elife; 2013 Jul; 2():e00712. PubMed ID: 23853713
[TBL] [Abstract][Full Text] [Related]
8. Norathyriol suppresses skin cancers induced by solar ultraviolet radiation by targeting ERK kinases.
Li J; Malakhova M; Mottamal M; Reddy K; Kurinov I; Carper A; Langfald A; Oi N; Kim MO; Zhu F; Sosa CP; Zhou K; Bode AM; Dong Z
Cancer Res; 2012 Jan; 72(1):260-70. PubMed ID: 22084399
[TBL] [Abstract][Full Text] [Related]
9. Total synthesis of LL-Z1640-2 utilizing a late-stage intramolecular Nozaki-Hiyama-Kishi reaction.
Leclair CA; Boxer MB; Thomas CJ; Maloney DJ
Tetrahedron Lett; 2010 Dec; 51(52):6852-6855. PubMed ID: 21516235
[TBL] [Abstract][Full Text] [Related]
10. Small-molecule inhibitors of the ERK signaling pathway: Towards novel anticancer therapeutics.
Yap JL; Worlikar S; MacKerell AD; Shapiro P; Fletcher S
ChemMedChem; 2011 Jan; 6(1):38-48. PubMed ID: 21110380
[No Abstract] [Full Text] [Related]
11. A computational workflow for the design of irreversible inhibitors of protein kinases.
Del Rio A; Sgobba M; Parenti MD; Degliesposti G; Forestiero R; Percivalle C; Conte PF; Freccero M; Rastelli G
J Comput Aided Mol Des; 2010 Mar; 24(3):183-94. PubMed ID: 20306284
[TBL] [Abstract][Full Text] [Related]
12. Enzymatic synthesis of resorcylic acid lactones by cooperation of fungal iterative polyketide synthases involved in hypothemycin biosynthesis.
Zhou H; Qiao K; Gao Z; Meehan MJ; Li JW; Zhao X; Dorrestein PC; Vederas JC; Tang Y
J Am Chem Soc; 2010 Apr; 132(13):4530-1. PubMed ID: 20222707
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of p38alpha kinase-targeting dialkynylimidazoles.
Li J; Kaoud TS; Laroche C; Dalby KN; Kerwin SM
Bioorg Med Chem Lett; 2009 Nov; 19(22):6293-7. PubMed ID: 19822424
[TBL] [Abstract][Full Text] [Related]
14. Molecular modeling and crystal structure of ERK2-hypothemycin complexes.
Rastelli G; Rosenfeld R; Reid R; Santi DV
J Struct Biol; 2008 Oct; 164(1):18-23. PubMed ID: 18571434
[TBL] [Abstract][Full Text] [Related]
15. Targeted covalent inactivation of protein kinases by resorcylic acid lactone polyketides.
Schirmer A; Kennedy J; Murli S; Reid R; Santi DV
Proc Natl Acad Sci U S A; 2006 Mar; 103(11):4234-9. PubMed ID: 16537514
[TBL] [Abstract][Full Text] [Related]
16. Conformational analyses and MO studies of f152A1 and its analogues as potent protein kinase inhibitors.
Ikemori-Kawada M; Kawai T; Goto M; Wang YJ; Kawakami Y
J Chem Inf Model; 2009 Dec; 49(12):2650-9. PubMed ID: 19995092
[TBL] [Abstract][Full Text] [Related]
17. Computational sampling of a cryptic drug binding site in a protein receptor: explicit solvent molecular dynamics and inhibitor docking to p38 MAP kinase.
Frembgen-Kesner T; Elcock AH
J Mol Biol; 2006 May; 359(1):202-14. PubMed ID: 16616932
[TBL] [Abstract][Full Text] [Related]
18. Cis-enone resorcylic acid lactones (RALs) as irreversible protein kinase inhibitors.
Wei L; Wu J; Li G; Shi N
Curr Pharm Des; 2012; 18(9):1186-98. PubMed ID: 22316158
[TBL] [Abstract][Full Text] [Related]
19. (5Z)-7-Oxozeaenol: A novel and potent resorcylic acid lactone kinase inhibitor with a cis-enone Michael acceptor.
Ellestad GA
Chirality; 2019 Feb; 31(2):110-117. PubMed ID: 30565749
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
